Cleared Traditional

K202306 - T3 Platform software

K202306 is an FDA 510(k) clearance for T3 Platform software, manufactured by Etiometry, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 103-day FDA review.

K202306 · Etiometry, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
103d
Days
Class 2
Risk

K202306 is an FDA 510(k) clearance for the T3 Platform software. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Etiometry, Inc. (Boston, US). The FDA issued a Cleared decision on November 25, 2020 after a review of 103 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Etiometry, Inc. devices

FDA 510(k) Submission Details - K202306

510(k) Number K202306 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2020
Decision Date November 25, 2020
Days to Decision 103 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 125d · This submission: 103d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 150
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K202306.
740 SafeSAT
K200160 · Zoe Medical, Inc. · Feb 2021
MouthLab Vital Signs Monitoring System
K201635 · Multisensor Diagnostics (Dba Aidar Health) · Feb 2021
Vital Signs Monitor:iM3s, iM3As, iM3Bs, iHM3s
K202892 · Edan Instruments, Inc. · Jan 2021
Masimo Rad-97 Pulse CO-Oximeter and Accessories
K193626 · Masimo Corporation · Aug 2020
SmartLinx Vitals Plus Patient Monitoring System
K200856 · Capsule Technologie Sas · Jul 2020
Oxi-W System
K200141 · Ld Technology, LLC · Apr 2020